Imaging findings and differential diagnosis of hepatic sinusoidal occlusion syndrome and Budd-Chiari syndrome
暂无分享,去创建一个
Cuiyu Jia | Hong Li | Ji Feng | Da-wei Zhao | Rui-Li Li | Xin Xin Wang
[1] F. Ravaioli,et al. Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation , 2020, Frontiers in Immunology.
[2] Lingling Meng,et al. Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study , 2020, BMC Gastroenterology.
[3] V. Vilgrain,et al. CT and MR imaging of chemotherapy-induced hepatopathy , 2019, Abdominal Radiology.
[4] Jianming Xu,et al. Quantitative Analysis of CT Images in Patients with Pyrrolizidine Alkaloid-Induced Sinusoidal Obstruction Syndrome , 2019, Scientific Reports.
[5] T. Bai,et al. Gadoxetic Acid-Enhanced Hepatobiliary-Phase Magnetic Resonance Imaging for Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome and Association with Liver Function , 2019, Scientific Reports.
[6] Varun Bansal,et al. Budd-Chiari syndrome: imaging review. , 2018, The British journal of radiology.
[7] A. Schulz,et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation , 2017, Bone Marrow Transplantation.
[8] M. Ronot,et al. Diagnosis of Budd–Chiari syndrome , 2018, Abdominal Radiology.
[9] T. Genet,et al. Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: Radio-pathological correlation. , 2017, European journal of radiology.
[10] X. Hou,et al. Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome , 2016, Scientific Reports.
[11] M. Abecassis,et al. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation , 2016, Bone Marrow Transplantation.
[12] O. Matsui,et al. Correlation between Gd-EOB-DTPA-enhanced MR imaging findings and OATP1B3 expression in chemotherapy-associated sinusoidal obstruction syndrome , 2015, Abdominal Imaging.
[13] Min Ju Kim,et al. Hepatic Parenchymal Heterogeneity on Contrast-enhanced CT Scans Following Oxaliplatin-based Chemotherapy: Natural History and Association with Clinical Evidence of Sinusoidal Obstruction Syndrome. , 2015, Radiology.
[14] J. Crawford,et al. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). , 2014, Journal of Clinical and Experimental Hepatology.
[15] Yi-Xiang J. Wang,et al. Hepatic Sinusoidal Obstruction Syndrome Caused by Herbal Medicine: CT and MRI Features , 2014, Korean journal of radiology.
[16] Hong Gao,et al. Tusanqi and hepatic sinusoidal obstruction syndrome , 2014, Journal of digestive diseases.
[17] G. Lin,et al. Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids , 2012, Journal of digestive diseases.
[18] G. Lin,et al. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. , 2011, Journal of hepatology.
[19] L. Rubbia‐Brandt,et al. Sinusoidal obstruction syndrome. , 2010, Clinics in liver disease.
[20] J. Huo,et al. Hepatic veno-occlusive disease associated with toxicity of pyrrolizidine alkaloids in herbal preparations. , 2010, The Netherlands journal of medicine.
[21] Allen R. Chen,et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[22] Y. Bayraktar,et al. Budd-Chiari syndrome: etiology, pathogenesis and diagnosis. , 2007, World journal of gastroenterology.
[23] Yan Jiang,et al. Deacetylclivorine: A Gender-Selective Metabolite of Clivorine Formed in Female Sprague-Dawley Rat Liver Microsomes , 2007, Drug Metabolism and Disposition.
[24] Sukru Mehmet Erturk,et al. CT features of hepatic venoocclusive disease and hepatic graft-versus-host disease in patients after hematopoietic stem cell transplantation. , 2006, AJR. American journal of roentgenology.
[25] D. Mitchell,et al. Budd‐chiari syndrome: Spectrum of appearances of acute, subacute, and chronic disease with magnetic resonance imaging , 2000, Journal of magnetic resonance imaging : JMRI.
[26] M. Kami,et al. Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution , 1997, Bone Marrow Transplantation.
[27] K. Tınaztepe,et al. Veno-occlusive disease of the liver. , 1967, The Turkish journal of pediatrics.
[28] H. Stein. Veno-occlusive Disease of Liver in African Children , 1957, British medical journal.